Akiko Miyagi Maeshima


Affiliation: National Cancer Center
Country: Japan


  1. Maeshima A, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H. Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol. 2010;5:333-9 pubmed publisher
    ..Minimally invasive adenocarcinomas did not recur in this large series. ..
  2. Maeshima A, Taniguchi H, Nomoto J, Makita S, Kitahara H, Fukuhara S, et al. Clinicopathological features of classical Hodgkin lymphoma in patients ≥ 40 years old, with special reference to composite cases. Jpn J Clin Oncol. 2015;45:921-8 pubmed publisher
    ..Correct diagnosis and optimal treatment for patients with composite classical Hodgkin lymphoma and B-cell non-Hodgkin lymphoma is highly important in this patient population. ..
  3. Ando Y, Maeshima A, Fukuhara S, Makita S, Munakata W, Suzuki T, et al. CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity. Int J Hematol. 2018;108:344-347 pubmed publisher
    ..The CHOP regimen was administered and complete remission achieved. This case indicated that EP should be considered as a differential diagnosis even when a tumor shows large cell morphology and is positive for CD3, CD56, and EBER1. ..
  4. Makita S, Maeshima A, Taniguchi H, Kitahara H, Fukuhara S, Munakata W, et al. Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma. Int J Hematol. 2016;104:396-9 pubmed publisher
  5. Nomoto J, Hiramoto N, Kato M, Sanada M, Maeshima A, Taniguchi H, et al. Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma. BMC Cancer. 2012;12:457 pubmed publisher
    ..This suggests that TNFAIP3 inactivation in primary cHL specimens might be more frequent than previously reported. ..
  6. Maeshima A, Tochigi N, Tsuta K, Asamura H, Matsuno Y. Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung. J Thorac Oncol. 2008;3:698-703 pubmed publisher
    ..As there is little information on the histologic characteristics of adenocarcinoma in smokers, we histologically examined the effect of smoking on the carcinogenesis and progression of peripheral small lung adenocarcinomas...
  7. Maeshima A, Taniguchi H, Nomoto J, Maruyama D, Kim S, Watanabe T, et al. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy. Cancer Sci. 2009;100:54-61 pubmed publisher
    ..In conclusion, B-NHL showed various histological and immunophenotypic changes after rituximab therapy, including not only CD20 loss but also proliferation of plasmacytoid cells or transformation to special subtypes of lymphoma...
  8. Maeshima A, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H. Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence. J Thorac Oncol. 2010;5:466-71 pubmed publisher
    ..Clarification of the clinicopathologic characteristics of patients with multiple atypical adenomatous hyperplasias (AAHs)...
  9. Maeshima A, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, et al. Comparison of clinicopathologic characteristics of gastric follicular lymphomas and duodenal follicular lymphomas. Hum Pathol. 2017;65:201-208 pubmed publisher

More Information


  1. Maeshima A, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, et al. Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016. Int J Hematol. 2017;106:675-680 pubmed publisher
    ..This distribution may serve as a reference for routine histologic diagnosis of lymphomas in the anterior mediastinum in Japan. ..